Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: Results of the CANWARD 2007-2009 study

Diagnostic Microbiology and Infectious Disease

Volumn 69, Issue 3, 2011, Pages 320-325

  Nichol, Kimberly A ^a   Adam, Heather J ^a,b   Hussain, Zafar ^c   Mulvey, Michael R ^b,d   McCracken, Melissa ^d   Mataseje, Laura F ^d   Thompson, Kristjan ^b   Kost, Sara ^b   Lagacé Wiens, Philippe R S ^a,b   Hoban, Daryl J ^a,b   Zhanel, George G ^b  

^a Diagnostic Services of Manitoba Inc   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Community associated; Hospital associated; MRSA

Indexed keywords

CEFAZOLIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; PANTON VALENTINE LEUKOCIDIN; TIGECYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CANADA; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; TOXIN ANALYSIS;

ACETAMIDES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CANADA; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DAPTOMYCIN; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; EXOTOXINS; FEMALE; HOSPITALS; HUMANS; INFANT; LEUKOCIDINS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINOCYCLINE; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 79951901013     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.10.028     Document Type: Article

References (23)

1. Adam H.J., Louie L., Watt C., Gravel D., Bryce E., Loeb M., Matlow A., McGeer A., Mulvey M.R., Simor A.E., Canadian Nosocomial Infection Surveillance Program Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006. Antimicrob. Agents Chemother. 2010, 54:945-949.
2. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard seventh edition 2006, CLSI, (M07-A7, Wayne, PA).
3. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing; twentieth informational supplement 2010, CLSI, (M100-S20, Wayne, PA).
4. Cummings K.L., Anderson D.J., Kaye K.S. Hand hygiene noncompliance and the cost of hospital-acquired methicillin-resistant Staphylococcus aureus or infection. Infect. Control. Hosp. Epidemiol. 2010, 31:357-364.
5. Golding G., Campbell J., Spreitzer D., Veyhl J., Surynicz K., Simor A., Mulvey M.R., Canadian Nosocomial Infection Surveillance Program A preliminary guideline for the assignment of methicillin-resistant Staphylococcus aureus to a Canadian pulsed-field gel electrophoresis epidemic type using spa typing. Can. J. Infect. Dis. Med. Microbiol. 2008, 19:273-281.
6. Hidayat L.K., Hsu D.I., Quist R., Shriner K.A., Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections. Arch. Intern. Med. 2006, 166:2138-2144.
7. Hoban D.J., Zhanel G.G. Introduction to the CANWARD study, 2007-2009. Diagn. Microbiol. Infect. Dis. 2011, 69:289-290.
8. McDonald R.R., Antonishyn N.A., Hansen T., Snook L.A., Nagle E., Mulvey M.R., Levett P.N., Horsman G.B. Development of a triplex real-time PCR assay for detection of Panton-Valentine leukocidin toxin genes in clinical isolates of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 2005, 43:6147-6149.
9. Moise-Broder P.A., Sakoulas G., Eliopoulos G.M., Schentag J.J., Forrest A., Moellering R.C. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin. Infec. Dis. 2004, 38:1700-1705.
10. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud S.M., Etienne J., Johnson S.K.J., Vandenesch F., Fridkin S., O'Boyle C., Danila R.N., Lynfield R. Comparison of community and healthcare-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290:2976-2984.
11. Nichol K.A., McCracken M., DeCorby M., Thompson K., Mulvey M.R., Karlowsky J.A., Hoban D.J., Zhanel G.G. Comparison of community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus in Canada: results from CANWARD 2007. Can. J. Infect. Dis. Med. Microbiol. 2009, 20(SupplA):31-36.
12. Otter J.A., French G.L. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect. Dis. 2010, 10:227-239.
13. Pakyz A.L., MacDougall C., Olinen M., Polk R.E. Trends in antibacterial use in US academic health centres. Arch. Intern. Med. 2008, 168:2254-2260.
14. Sakoulas G., Moise-Broder P.A., Schentag J.J., Forrest A., Moellering R.C., Eliopoulos G.M. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 2004, 42:2398-2402.
15. Shopsin B., Mathema B., Alcabes P., Said-Salim B., Lina G., Matsuka A., Martinez J., Kreiswirth B.N. Prevalence of agr specificity groups among Staphylococcus aureus strains colonizing children and their guardians. J. Clin. Microbiol. 2003, 41:456-459.
16. Simor A.E., Gilbert N.L., Gravel D., Mulvey M.R., Bryce E., Loeb M., Matlow A., McGeer A., Louie L., Campbell J., Canadian Nosocomial Infection Surveillance Program Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: national surveillance of changing epidemiology, 1995-2007. Infect. Control. Hosp. Epidemiol. 2010, 31:348-356.
17. Simor A.E., Louie L., Watt C., Gravel D., Mulvey M.R., Campbell J., McGeer A., Bryce E., Loeb M., Matlow A., Canadian Nosocomial Infection Surveillance Program Antimicrobial susceptibilities of healthcare-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada 1995-2008. Antimicrobial. Agents Chemother. 2010, 54:2265-2268.
18. Tristan A., Ferry T., Durand G., Dauwalder O., Bes M., Lina G., Vandenesch F., Etienne J. Virulence determinants in community and hospital meticillin-resistant Staphylococcus aureus. J. Hosp. Infect. 2007, 65:105-109.
19. Wang G., Hindler J.F., Ward K.W., Bruckner D.A. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a University hospital during a 5 year period. J. Clin. Microbiol. 2006, 44:3883-3886.
20. Zelenitsky S., Ariano R., Weber Z., Alkurdi N., Zhanel G.G. Preventing resistance during continuous infusion (CI) vancomycin (vanco) against methicillin-resistant Staphylococcus aureus in an in vitro model 2010.
21. Zhanel G.G., Adam H.J., Low D.E., Blondeau J., DeCorby M., Karlowsky J., Weshnoweski B., Vashisht R., Wierzbowski A., Hoban D.J. Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007-2009 study. Diagn. Microbiol. Infect. Dis. 2011, 69:291-306. the Canadian Antimicrobial Resistance Alliance.
22. Zhanel G.G., DeCorby M., Adam H., Mulvey M.R., McCracken M., Lagace-Wiens P.R., Nichol K.A., Wierzbowski A., Baudry P.J., Tailor F., Karlowsky J.A., Walkty A., Schweizer F., Johnson J., Hoban D.J. Prevalence of antimicrobial resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008). Antimicrob. Agents Chemother. 2010, 54:4684-4693. The Canadian Antimicrobial Resistance Alliance (CARA).
23. Zhang K., McClure J.A., Elsayed S., Louie T., Conly J.M. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 2005, 43:5026-5033.